Folger Nolan Fleming Douglas Capital Management, Inc Bristol Myers Squibb CO Transaction History
Folger Nolan Fleming Douglas Capital Management, Inc
- $839 Million
- Q2 2025
A detailed history of Folger Nolan Fleming Douglas Capital Management, Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Folger Nolan Fleming Douglas Capital Management, Inc holds 12,046 shares of BMY stock, worth $553,513. This represents 0.07% of its overall portfolio holdings.
Number of Shares
12,046
Previous 12,779
5.74%
Holding current value
$553,513
Previous $779,000
28.5%
% of portfolio
0.07%
Previous 0.1%
Shares
29 transactions
Others Institutions Holding BMY
# of Institutions
2,677Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA191MShares$8.79 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...